GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » International Isotopes Inc (OTCPK:INIS) » Definitions » EV-to-EBIT

International Isotopes (International Isotopes) EV-to-EBIT : -40.45 (As of May. 03, 2024)


View and export this data going back to 1997. Start your Free Trial

What is International Isotopes EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, International Isotopes's Enterprise Value is $21.72 Mil. International Isotopes's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.54 Mil. Therefore, International Isotopes's EV-to-EBIT for today is -40.45.

The historical rank and industry rank for International Isotopes's EV-to-EBIT or its related term are showing as below:

INIS' s EV-to-EBIT Range Over the Past 10 Years
Min: -157.08   Med: -20.15   Max: 18063.07
Current: -40.45

During the past 13 years, the highest EV-to-EBIT of International Isotopes was 18063.07. The lowest was -157.08. And the median was -20.15.

INIS's EV-to-EBIT is ranked worse than
100% of 667 companies
in the Drug Manufacturers industry
Industry Median: 17.89 vs INIS: -40.45

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. International Isotopes's Enterprise Value for the quarter that ended in Dec. 2023 was $22.38 Mil. International Isotopes's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.54 Mil. International Isotopes's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -2.40%.


International Isotopes EV-to-EBIT Historical Data

The historical data trend for International Isotopes's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

International Isotopes EV-to-EBIT Chart

International Isotopes Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -39.34 8.39 17,076.97 20.07 -41.68

International Isotopes Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.07 -29.17 -66.86 -46.92 -41.68

Competitive Comparison of International Isotopes's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, International Isotopes's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


International Isotopes's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, International Isotopes's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where International Isotopes's EV-to-EBIT falls into.



International Isotopes EV-to-EBIT Calculation

International Isotopes's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=21.721/-0.537
=-40.45

International Isotopes's current Enterprise Value is $21.72 Mil.
International Isotopes's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.54 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


International Isotopes  (OTCPK:INIS) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

International Isotopes's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=-0.537/22.38452
=-2.40 %

International Isotopes's Enterprise Value for the quarter that ended in Dec. 2023 was $22.38 Mil.
International Isotopes's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.54 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


International Isotopes EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of International Isotopes's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


International Isotopes (International Isotopes) Business Description

Traded in Other Exchanges
N/A
Address
4137 Commerce Circle, Idaho Falls, ID, USA, 83401
International Isotopes Inc manufactures a full range of nuclear medicine calibration and reference standards, cobalt teletherapy sources, and other sealed sources. International Isotopes also distributes a varied selection of radioisotopes and radiochemicals for medical and clinical research, and pharmacy compounding. International Isotopes's business consists of four business segments: Nuclear Medicine Standards, Cobalt Products, Radiochemical Products, and Fluorine Products. Geographically, it generates the majority of its revenue from the United States.
Executives
W Matthew Cox officer: Chief Financial Officer C/O INTERNATIONAL ISOTOPES INC., 4137 COMMERCE CIRCLE, IDAHO FALLS ID 83401
Shahe Bagerdjian officer: President 4137 COMMERCE CIRCLE, IDAHO FALLS ID 83401
Christopher G Grosso director, 10 percent owner C/O KERSHNER GROSSO & CO, 480 BROADWAY, SARASOTA SPRINGS NY 12866
Robert Atcher director 4137 COMMERCE CIRCLE, IDAHO FALLS ID 83401
Laurie Mckenzie-carter officer: Chief Financial Officer 4137 COMMERCE CIRCLE, IDAHO FALLS ID 83401
Steve Laflin director, officer: Pres. & CEO 1258 E AIRPORT ROAD, BLACKFOOT ID 83221
William W Nicholson 10 percent owner 121 NORTH POST OAK LANE STE 2105, HOUSTON TX 77024
Ralph M Richard director, 10 percent owner 350 SHORE DRIVE, OAKDALE NY 11769
John M Mccormack 10 percent owner 4137 COMMERCE CIRCLE, IDAHO FALLS ID 83401
Walter D Ohearn other: Part of 13D group 1115 5TH AVENUE, NEW YORK NY 10128
Keane Marie C & Keane James Jtwros 10 percent owner